Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Actos (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 18
» View latimes.com items only
    Dec 4, 2009 | Los Angeles Times

  1. Sulfonylureas for diabetes increase risk of heart disease and death, study finds

    Booster Shots
    Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
    2. Nov 13, 2012 |Story| LAT Brand Publishing

  2. Girardi | Keese

    <span style="font-size: large;">&ldquo;It&rsquo;s critical that consumers be&nbsp;allowed to band together to take&nbsp;on rich, powerful corporations.&rdquo;</span>&nbsp;<span style="font-size: large; text-align: right;">&mdash;Graham LippSmith</span>
    Firm Makes an Art of Joining Forces for Major Impact
    “It’s critical that consumers be allowed to band together to take on rich, powerful corporations.” —Graham LippSmith Some of the most important tools a lawyer has to help injured people are class and mass actions. Such lawsuits...

    Tags: Diabetes, Fosamax (drug), Osteoporosis, Merck & Company Incorporated, Insurance

    3. May 12, 2013 |Story| Herald Mail

  3. Shop around for deals on prescription drugs

    If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...

    Tags: Medicines, CVS Corp., Clopidogrel (drug), Singulair (drug), Diabetes

    4. Apr 15, 2013 |Story| WSBT-TV

  4. CONSUMER REPORTS: Big name drug savings

    If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver.
    If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver. But are you saving as much as you should? Consumer Reports has discovered just because you're buying a generic drug doesn't mean you're...

    Tags: CVS Corp., Singulair (drug), Diabetes, Prescription Drugs, Lexapro (drug)

    5. Mar 26, 2012 |Story| Los Angeles Times

  5. Robinson Calcagnie Robinson Shapiro Davis, Inc.

    From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades.
    From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades. Robinson Calcagnie Robinson Shapiro Davis, Inc. specializes in...

    Tags: Amputation, Machine Manufacturing, Transportation Accidents, Fosamax (drug), Occupational Safety and Health Administration

    6. Aug 1, 2012 |Story| Chicago Tribune

  6. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Diabetes, Prescription Drugs, Sjogren's Syndrome, Fosamax (drug), Behavioral Conditions

    7. Nov 30, 2011 |Story| Los Angeles Times
  7. |Story
    8. Feb 7, 2011 |Story| Reuters
  8. |Story

    Tags: Takeda Pharmaceutical Company Limited, Health, IMS Health Incorporated, Diabetes, Heart Problems

    9. Oct 26, 2009 |Story| Los Angeles Times

  9. Patients kick the insulin habit through diet, exercise

    By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that had been spiraling downward for years. Here's how they did it:
    By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that...

    Tags: Feet, Diabetes, Sports, University of California, Berkeley, Marathon

    10. Jul 13, 2010 |Story| Associated Press

  10. Avandia Hearings Expose FDA Rifts

    The diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?
    AP Business Writer
    The diabetes pill Avandia has been used by millions of patients and racked up billions in sales in more than a decade on the market. This week the Food and Drug Administration is trying to answer a seemingly simple question: Does it cause heart attacks?...

    Tags: Medical Research, Health, IMS Health Incorporated, Diabetes, Science

    11. Sep 27, 2010 |Story| Hola Hoy
  11. |Story

    Tags: Chile, Santiago (Chile), NASA

    12. Aug 30, 2007 |Story| Chicago Tribune

  12. Sales stay healthy for Takeda diabetes pill

    About one month after a Food and Drug Administration advisory panel said the diabetes pill Avandia should remain on the market but with strict warnings about heart attack risk, a similar pill sold by a Deerfield-based drugmaker is holding its own in the...

    Tags: Avandia (drug), Health, Heart Attack, Diseases and Illnesses, Diabetes

 1  2 • Next >
Advertisement